FDA Reverses Stance on Leucovorin for Autism

By News Health
2 months Ago

(MedPage Today) — The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday.
Leucovorin is…

Source link : https://www.medpagetoday.com/neurology/autism/120245

Author :

Publish date : 2026-03-10 21:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Antidepressants in Pregnancy: What a New Study Found

Supreme Court Preserves Access to Mifepristone While Lawsuit Plays Out

More Americans Being Monitored for Hantavirus Than Previously Known

New AML Regimen for Unfit Patients Gets FDA's Blessing

Summer Public Health-Maxxing; Ob/Gyns Celebrate PCOS Renaming; K for Bebe?

Here's How Many Hospitals Earned Five Stars From CMS